Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Skybiotech Healthcare Ltd (NSE: SKYBIOTECH), ISIN INE393H01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SKYBIOTECH last traded at ₹115.05 (+0.00%), with a 52-week range of ₹115.00 to ₹220.00 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 63.48%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 20/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.